Here is what you need to know on Thursday, December 10:
Markets are licking their wounds after a down day on Wednesday. Sentiment was pushed lower by the lack of a breakthrough in Brexit, which has a new Sunday deadline, and US fiscal stimulus talks, which remain stuck. The ECB is set to add stimulus and US data is of interest.
Brexit: UK Prime Minister Boris Johnson and European Commission President Ursula von der Leyen failed to reach a breakthrough after a long dinner in Brussels. The EU and the UK agreed to extend talks until Sunday and said they are far apart. GBP/USD is trading in the lower edge of the range. The bloc's leaders meet on Thursday to take stock of negotiations and other topics.
US fiscal stimulus: Democrats and Republicans are still at odds over aid to states and liability clauses. The House passed a week-long stopgap bill, for now. In the meantime, the number of daily COVID-19 US deaths surpassed 3,000 for the first time. Hospitals are under growing pressure, with yet another record above 106,000 on Wednesday.
Stocks dropped also in response to a lawsuit brought against Facebook, accusing it of monopoly powers. Tech stocks dragged the mood lower. Outgoing President Donald Trump is making a last-ditch effort to overturn the election results with a lawsuit which is at the doors of the Supreme Court. The Electoral College convenes on Monday and is set to formalize President-elect Joe Biden's victory.
The European Central Bank is projected to add around €500 billion to its Pandemic Emergency Purchase Program (PEPP). The additional stimulus is mostly priced in by markets. ECB President Christine Lagarde could comment on the euro's rising exchange rate, which depresses inflation and exports. Any hints of cutting the depost rate, which is at -0.50% would send the euro down.
See ECB Preview: Three charts show why Lagarde could send EUR/USD tumbling
Vaccine: The US Food and Drugs Administration is set to approve the Pfizer/BioNTech coronavirus immunization on Thursday, following Canada's greenlight on Wednesday and Britain's approval last week. The FDA is considered the global Gold Standard.
US weekly jobless claims are set to remain above 700,000 after dropping last week after Wednesday's JOLTs job openings surprised to the upside in October. Consumer Price Index figures for November are forecast to show an uptick in inflation, one week ahead of the Federal Reserve's decision.
See US Initial Jobless Claims: Less indicative than emotional
Gold is consolidating its losses around $1,840 as traders assess the diminishing chances of US stimulus. Oil has failed to advance amid reports that production cuts' compliance has been weak among OPEC members.
Cryptocurrencies have stabilized in lower ground, with Bitcoin changing hands at around $18,300.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD holds gains above 1.0700, as key US data loom
EUR/USD holds gains above 1.0700 in the European session on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data.
GBP/USD extends recovery above 1.2500, awaits US GDP data
GBP/USD is catching a fresh bid wave, rising above 1.2500 in European trading on Thursday. The US Dollar resumes its corrective downside, as traders resort to repositioning ahead of the high-impact US advance GDP data for the first quarter.
Gold price edges higher amid weaker USD and softer risk tone, focus remains on US GDP
Gold price (XAU/USD) attracts some dip-buying in the vicinity of the $2,300 mark on Thursday and for now, seems to have snapped a three-day losing streak, though the upside potential seems limited.
XRP extends its decline, crypto experts comment on Ripple stablecoin and benefits for XRP Ledger
Ripple extends decline to $0.52 on Thursday, wipes out weekly gains. Crypto expert asks Ripple CTO how the stablecoin will benefit the XRP Ledger and native token XRP.
US Q1 GDP Preview: Economic growth set to remain firm in, albeit easing from Q4
The United States Gross Domestic Product (GDP) is seen expanding at an annualized rate of 2.5% in Q1. The current resilience of the US economy bolsters the case for a soft landing.